Marie-Claude Bourgeois-Daigneault
Marie-Claude Bourgeois-Daigneault
CR-CHUM, Montreal
No verified email
Cited by
Cited by
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
J Hsu, JJ Hodgins, M Marathe, CJ Nicolai, MC Bourgeois-Daigneault, ...
The Journal of clinical investigation 128 (10), 4654-4668, 2018
Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy
MC Bourgeois-Daigneault, DG Roy, AS Aitken, N El Sayes, NT Martin, ...
Science translational medicine 10 (422), eaao1641, 2018
Methionine metabolism shapes T helper cell responses through regulation of epigenetic reprogramming
DG Roy, J Chen, V Mamane, EH Ma, BM Muhire, RD Sheldon, ...
Cell metabolism 31 (2), 250-266. e9, 2020
Interleukin‐10‐induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes
J Thibodeau, MC Bourgeois‐Daigneault, G Huppé, J Tremblay, A Aumont, ...
European journal of immunology 38 (5), 1225-1230, 2008
Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy
J Thibodeau, MC Bourgeois-Daigneault, R Lapointe
Oncoimmunology 1 (6), 908-916, 2012
VEGF-mediated induction of PRD1-BF1/Blimp1 expression sensitizes tumor vasculature to oncolytic virus infection
R Arulanandam, C Batenchuk, FA Angarita, K Ottolino-Perry, ...
Cancer Cell 28 (2), 210-224, 2015
Sorting of MHC class II molecules into exosomes through a ubiquitin‐independent pathway
MÉ Gauvreau, MH Côté, MC Bourgeois‐Daigneault, LD Rivard, F Xiu, ...
Traffic 10 (10), 1518-1527, 2009
Oncolytic vesicular stomatitis virus expressing interferon-σ has enhanced therapeutic activity
MC Bourgeois-Daigneault, DG Roy, T Falls, K Twumasi-Boateng, ...
Molecular Therapy-Oncolytics 3, 2016
Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment
MC Bourgeois-Daigneault, LE St-Germain, DG Roy, A Pelin, AS Aitken, ...
Breast Cancer Research 18 (1), 1-10, 2016
MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels
A Nagarajan, MC Petersen, AR Nasiri, G Butrico, A Fung, HB Ruan, ...
Nature communications 7 (1), 12639, 2016
Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation
R Veinalde, C Grossardt, L Hartmann, MC Bourgeois-Daigneault, JC Bell, ...
Oncoimmunology 6 (4), e1285992, 2017
Amplification of oncolytic vaccinia virus widespread tumor cell killing by sunitinib through multiple mechanisms
M Kim, M Nitschké, B Sennino, P Murer, BJ Schriver, A Bell, ...
Cancer research 78 (4), 922-937, 2018
Autoregulation of MARCH1 expression by dimerization and autoubiquitination
MC Bourgeois-Daigneault, J Thibodeau
The Journal of Immunology 188 (10), 4959-4970, 2012
Taking a stab at cancer; oncolytic virus-mediated anti-cancer vaccination strategies
AS Aitken, DG Roy, MC Bourgeois-Daigneault
Biomedicines 5 (1), 3, 2017
Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination
DG Roy, K Geoffroy, M Marguerie, ST Khan, NT Martin, J Kmiecik, ...
Nature Communications 12 (1), 2626, 2021
Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer
NT Martin, DG Roy, ST Workenhe, DJM Van Den Wollenberg, ...
Scientific reports 9 (1), 1865, 2019
MARCH1 E3 ubiquitin ligase dampens the innate inflammatory response by modulating monocyte functions in mice
T Galbas, M Raymond, A Sabourin, MC Bourgeois-Daigneault, ...
The Journal of Immunology 198 (2), 852-861, 2017
In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity
AL Jenner, T Cassidy, K Belaid, MC Bourgeois-Daigneault, M Craig
Journal for immunotherapy of cancer 9 (2), 2021
The pros and cons of interferons for oncolytic virotherapy
K Geoffroy, MC Bourgeois-Daigneault
Cytokine & Growth Factor Reviews 56, 49-58, 2020
Cutting edge: HLA-DO impairs the incorporation of HLA-DM into exosomes
F Xiu, MH Côté, MC Bourgeois-Daigneault, A Brunet, MÉ Gauvreau, ...
The Journal of Immunology 187 (4), 1547-1551, 2011
The system can't perform the operation now. Try again later.
Articles 1–20